Company / Depreciation & Amortization
Revvity Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$405.3M
FY2025
5-year range
$311.4M / $431.8M
FY2021-FY2025
Trend
-5.3%
vs FY2024
Sector context
#29 of 142
Health Care
What the data says
Revvity's depreciation & amortization of $405M is higher than 80% of companies in the Health Care sector (FY2025). Depreciation & Amortization has fluctuated over the past 10 years, ranging from $100M in FY2016 to $432M in FY2023.
Based on SEC 10-K filings.
$405M in FY2025 with a 5-year CAGR of +15.0%. Top quartile in the Health Care sector.
Improved from $432M to $405M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -1.7%
- 5-Year CAGR
- +15.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 142This company $405.3M Sector average $347.4M
▼
+16.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +15.0%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 5.3% year-over-year.
- Ranks #29 out of 142 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $405.3M | -5.3% |
| FY2024 | $427.8M | -0.9% |
| FY2023 | $431.8M | +1.1% |
| FY2022 | $427.0M | +37.1% |
| FY2021 | $311.4M | +54.4% |
| FY2020 | $201.6M | -5.8% |
| FY2019 | $214.0M | +18.5% |
| FY2018 | $180.6M | +72.0% |
| FY2017 | $105.0M | +5.0% |
| FY2016 | $100.0M | -5.1% |
As of FY2025 · SEC 10-K · Updated Mar 14, 2026